These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7011722)

  • 1. Comparison of biosynthetic human insulin and pork insulin in the Gerritzen test.
    Weinges K; Ehrhardt M; Enzmann F
    Diabetes Care; 1981; 4(2):180-2. PubMed ID: 7011722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin.
    Federlin K; Laube H; Velcovsky HG
    Diabetes Care; 1981; 4(2):170-4. PubMed ID: 7011720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat.
    Halban PA; Berger M; Gjinovci A; Renold AE
    Diabetes Care; 1981; 4(2):238-43. PubMed ID: 7011735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin.
    Viberti GC; Pickup JC; Keen H; Bilous RW; Mattock M; Jarrett RJ; Glynne A; Rogers R
    Diabetes Care; 1981; 4(2):175-9. PubMed ID: 7011721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system.
    Klier M; Kerner W; Torres AA; Pfeiffer EF
    Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of human insulin (recombinant DNA)--regular, NPH, and mixtures--obtained by the Gerritzen method in healthy volunteers.
    Weinges K; Ehrhardt M; Nell G; Enzmann F
    Diabetes Care; 1982; 5 Suppl 2():67-70. PubMed ID: 6765545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins.
    Galloway JA; Spradlin CT; Root MA; Fineberg SE
    Diabetes Care; 1981; 4(2):183-8. PubMed ID: 7011723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects.
    Massi-Benedetti M; Burrin JM; Capaldo B; Alberti KG
    Diabetes Care; 1981; 4(2):163-7. PubMed ID: 7011718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthetic human insulin: pharmacokinetics and effects in healthy human volunteers.
    Brogard JM; Blickle JF; Pinget M; Stahl A; Dorner M
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):575-80. PubMed ID: 6360919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus.
    Gerich JE
    Diabetes Care; 1981; 4(2):262-4. PubMed ID: 7011743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and hormonal parameters after insulin-induced hypoglycemia in man, comparison between biosynthetic human insulin and purified pork insulin.
    Perez Fernandez R; Casanueva FF; Devesa J; Cabezas-Cerrato J
    Horm Metab Res; 1985 Jul; 17(7):351-4. PubMed ID: 2993143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the biologic actions of biosynthetic human insulin in vitro and in diabetic man.
    Waldhäusl WK; Kastner G; Komjati M; Bratusch-Marrain P
    Diabetes Care; 1981; 4(2):205-8. PubMed ID: 7011728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
    Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
    Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin binding, biologic activity, and metabolism of biosynthetic human insulin.
    Olefsky JM
    Diabetes Care; 1981; 4(2):244-7. PubMed ID: 7011736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of hormonal counter-regulation during GCIIS-guided insulin hypoglycemia tests using human insulin (recombinant DNA) and pork insulin.
    Müller-Esch G; Ball P; Bekemeyer U; Heidbüchel K; Kraas E; vd Lühe C; Tybussek R; Wood WG; Scriba PC
    Diabetes Res; 1985 May; 2(3):121-5. PubMed ID: 2998678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic properties of biosynthetic human insulin in vitro.
    Beischer W; Maier V; Jonatha EM; Hartweg D; Kratzsch G
    Diabetes Care; 1981; 4(2):202-4. PubMed ID: 7011727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative potencies of human and pork insulin during i.v. and oral glucose tolerance test in lean and obese persons.
    Nesher R; Sinai J; Litvin Y; Cerasi E
    Isr J Med Sci; 1985 Nov; 21(11):905-11. PubMed ID: 3908398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas.
    Raptis S; Karaiskos C; Enzmann F; Hatzidakis D; Zoupas C; Souvatzoglou A; Diamantopoulos E; Moulopoulos S
    Diabetes Care; 1981; 4(2):155-62. PubMed ID: 7011717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects.
    Waldhäusl WK; Gasić S; Bratusch-Marrain P; Korn A; Nowotny P
    Am J Physiol; 1982 Dec; 243(6):E476-82. PubMed ID: 6756164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.